Literature DB >> 32404402

Maternal cardiovascular risk after hypertensive disorder of pregnancy.

Clare Arnott1,2,3,4, Michael Nelson5, Maria Alfaro Ramirez5, Jon Hyett3,6, Marianne Gale7, Amanda Henry8,9, David S Celermajer1,3, Lee Taylor5, Mark Woodward10,11,12.   

Abstract

BACKGROUND AND
OBJECTIVE: Hypertensive disorders of pregnancy (HDPs) affect 5%-10% of pregnancies and have been associated with excess maternal cardiovascular disease (CVD) risk. The primary aim of this study was to reliably estimate absolute and relative risks of CVD after HDP.
METHODS: A retrospective cohort of women who had singleton pregnancies in New South Wales, Australia, between 2002 and 2016 and identified using linked population health administrative databases. The primary exposure was new-onset HDP (pre-eclampsia/eclampsia and gestational hypertension), and the endpoint was hospitalisation or death due to ischaemic or hypertensive heart disease, or stroke. Kaplan-Meier analysis estimated risks among mothers following their first birth, and multivariable time-dependent Cox regression estimated the association between HDP and CVD.
RESULTS: Among 528 106 women, 10.3% experienced HDP in their first pregnancy. The 10-year estimated risk of CVD was 2.1 per 1000 if no HDP and 5.5 per 1000 following HDP. Adjusting for demographics, gestational diabetes, small for gestational age and preterm birth, we found that there was an interaction between smoking and HDP, and a larger effect of early-onset (<34 weeks) HDP, compared with late-onset HDP. The HR for women with early-onset HDP who did not smoke was 4.90 (95% CI 3.00 to 7.80) and the HR for those who did smoke was 23.5 (95% CI 13.5 to 40.5), each compared with women without HDP who did not smoke.
CONCLUSION: In this nationally representative Australian cohort, HDP, especially early onset, conferred a clear increase in the risk of CVD, with amplification by smoking. Targeted preventive health, during and after pregnancy, could prevent a substantial burden of CVD among childbearing women. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diabetes; hypertension; pregnancy; smoking cessation

Mesh:

Year:  2020        PMID: 32404402     DOI: 10.1136/heartjnl-2020-316541

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):: A Randomized Double-Blind Placebo-Controlled Feasibility Trial.

Authors:  Laura Ormesher; Suzanne Higson; Matthew Luckie; Stephen A Roberts; Heather Glossop; Andrew Trafford; Elizabeth Cottrell; Edward D Johnstone; Jenny E Myers
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

Review 2.  Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women.

Authors:  Anna C O'Kelly; Erin D Michos; Chrisandra L Shufelt; Jane V Vermunt; Margo B Minissian; Odayme Quesada; Graeme N Smith; Janet W Rich-Edwards; Vesna D Garovic; Samar R El Khoudary; Michael C Honigberg
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

3.  Clinician Knowledge and Practices Related to a Patient History of Hypertensive Disorders of Pregnancy.

Authors:  Nicole D Ford; Cheryl L Robbins; Nina Nandi; Donald K Hayes; Fleetwood Loustalot; Elena Kuklina; Jean Y Ko
Journal:  Obstet Gynecol       Date:  2022-04-05       Impact factor: 7.623

4.  Optimising mothers' health behaviour after hypertensive disorders of pregnancy: a qualitative study of a postnatal intervention.

Authors:  Chris Rossiter; Amanda Henry; Lynne Roberts; Mark A Brown; Megan Gow; Clare Arnott; Justine Salisbury; Annette Ruhotas; Angela Hehir; Elizabeth Denney-Wilson
Journal:  BMC Public Health       Date:  2022-06-27       Impact factor: 4.135

5.  Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association.

Authors:  Vesna D Garovic; Ralf Dechend; Thomas Easterling; S Ananth Karumanchi; Suzanne McMurtry Baird; Laura A Magee; Sarosh Rana; Jane V Vermunt; Phyllis August
Journal:  Hypertension       Date:  2021-12-15       Impact factor: 9.897

Review 6.  Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.

Authors:  Allison B Reiss; Benna Jacob; Saba Ahmed; Steven E Carsons; Joshua DeLeon
Journal:  Inflammation       Date:  2021-04-05       Impact factor: 4.092

7.  Assessing knowledge of healthcare providers concerning cardiovascular risk after hypertensive disorders of pregnancy: an Australian national survey.

Authors:  Heike Roth; Caroline S E Homer; Clare Arnott; Lynne Roberts; Mark Brown; Amanda Henry
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-23       Impact factor: 3.007

8.  Assessing Australian women's knowledge and knowledge preferences about long-term health after hypertensive disorders of pregnancy: a survey study.

Authors:  Heike Roth; Caroline S E Homer; Grace LeMarquand; Lynne M Roberts; LIsa Hanley; Mark Brown; Amanda Henry
Journal:  BMJ Open       Date:  2020-12-17       Impact factor: 2.692

Review 9.  Use of Race, Ethnicity, and National Origin in Studies Assessing Cardiovascular Risk in Women With a History of Hypertensive Disorders of Pregnancy.

Authors:  Amy Johnston; Victrine Tseung; Sonia R Dancey; Sarah M Visintini; Thais Coutinho; Jodi D Edwards
Journal:  CJC Open       Date:  2021-08-20

10.  Maternal Adiposity and Energy Balance After Normotensive and Preeclamptic Pregnancies.

Authors:  Sarah L McLennan; Amanda Henry; Lynne M Roberts; Sai S Siritharan; Melissa Ojurovic; Amanda Yao; Gregory K Davis; George Mangos; Franziska Pettit; Mark A Brown; Anthony J O'Sullivan
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.